Human	B-protein
T	I-protein
cell	I-protein
transcription	I-protein
factor	I-protein
GATA-3	B-protein
stimulates	O
HIV-1	O
expression	O
.	O

A	O
family	O
of	O
transcriptional	O
activating	O
proteins	O
,	O
the	O
GATA	B-protein
factors	I-protein
,	O
has	O
been	O
shown	O
to	O
bind	O
to	O
a	O
consensus	O
motif	O
through	O
a	O
highly	B-protein
conserved	I-protein
C4	I-protein
zinc	I-protein
finger	I-protein
DNA	I-protein
binding	I-protein
domain	I-protein
.	O

One	O
member	O
of	O
this	O
multigene	O
family	O
,	O
GATA-3	B-protein
,	O
is	O
most	O
abundantly	O
expressed	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
a	O
cellular	O
target	O
for	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
and	O
replication	O
.	O

In	O
vitro	O
DNase	B-protein
I	I-protein
footprinting	O
analysis	O
revealed	O
six	O
hGATA-3	B-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
U3	B-DNA
region	I-DNA
(	O
the	O
transcriptional	B-DNA
regulatory	I-DNA
domain	I-DNA
)	O
of	O
the	O
HIV-1	B-DNA
LTR	I-DNA
.	O

Cotransfection	O
of	O
an	O
hGATA-3	B-DNA
expression	I-DNA
plasmid	I-DNA
with	O
a	O
reporter	B-DNA
plasmid	I-DNA
whose	O
transcription	O
is	O
directed	O
by	O
the	O
HIV-1	B-DNA
LTR	I-DNA
resulted	O
in	O
6-	O
to	O
10-fold	O
stimulation	O
of	O
LTR	B-DNA
-mediated	O
transcription	O
,	O
whereas	O
site	O
specific	O
mutation	O
of	O
these	O
GATA	B-DNA
sites	I-DNA
resulted	O
in	O
virtual	O
abrogation	O
of	O
the	O
activation	O
by	O
hGATA-3	B-protein
.	O

Further	O
,	O
deletion	O
of	O
the	O
hGATA-3	B-DNA
transcriptional	I-DNA
activation	I-DNA
domain	I-DNA
abolished	O
GATA-dependent	O
HIV-1	O
trans-activation	O
,	O
showing	O
that	O
the	O
stimulation	O
of	O
viral	O
transcription	O
observed	O
is	O
a	O
direct	O
effect	O
of	O
cotransfected	B-protein
hGATA-3	I-protein
.	O

Introduction	O
of	O
the	O
HIV-1	B-DNA
plasmids	I-DNA
in	O
which	O
the	O
GATA	B-DNA
sites	I-DNA
have	O
been	O
mutated	O
into	O
human	O
T	B-cell_type
lymphocytes	I-cell_type
also	O
caused	O
a	O
significant	O
reduction	O
in	O
LTR	B-DNA
-mediated	O
transcription	O
at	O
both	O
the	O
basal	O
level	O
and	O
in	O
(	O
PHA-	O
plus	O
PMA-	O
)	O
stimulated	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

These	O
observations	O
suggest	O
that	O
in	O
addition	O
to	O
its	O
normal	O
role	O
in	O
T	B-cell_type
lymphocyte	I-cell_type
gene	O
regulation	O
,	O
hGATA-3	B-protein
may	O
also	O
play	O
a	O
significant	O
role	O
in	O
HIV-1	O
transcriptional	O
activation	O
.	O

©	NULL
1993	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

12	NULL
2831-2836	NULL
Human	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
stimulates	NULL
HIV-1	NULL
expression	NULL
Zhuoying	NULL
Yang	NULL
and	NULL
James	NULL
Douglas	NULL
Engel	NULL
!	NULL

*	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Molecular	NULL
Biology	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Northwestern	NULL
University	NULL
,	NULL
Evanston	NULL
,	NULL
IL	NULL
60208-3500	NULL
,	NULL
USA	NULL
Received	NULL
March	NULL
30	NULL
,	NULL
1993	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
May	NULL
6	NULL
,	NULL
1993	NULL
ABSTRACT	NULL
A	NULL
family	NULL
of	NULL
transcriptional	NULL
activating	NULL
proteins	NULL
,	NULL
the	NULL
GATA	NULL
factors	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
consensus	NULL
motif	NULL
through	NULL
a	NULL
highly	NULL
conserved	NULL
C	NULL
,	NULL
zinc	NULL
finger	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

One	NULL
member	NULL
of	NULL
this	NULL
multigene	NULL
family	NULL
,	NULL
GATA-3	NULL
,	NULL
is	NULL
most	NULL
abundantly	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
a	NULL
cellular	NULL
target	NULL
for	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
infection	NULL
and	NULL
replication	NULL
.	NULL

In	NULL
vitro	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
revealed	NULL
six	NULL
hGATA-3	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
U3	NULL
region	NULL
(	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
domain	NULL
)	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Cotransfection	NULL
of	NULL
an	NULL
hGATA-3	NULL
expression	NULL
plasmid	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
whose	NULL
transcription	NULL
is	NULL
directed	NULL
by	NULL
the	NULL
HIV-1	NULL
LTR	NULL
resulted	NULL
in	NULL
6-	NULL
to	NULL
10-fold	NULL
stimulation	NULL
of	NULL
LTR-mediated	NULL
transcription	NULL
,	NULL
whereas	NULL
site	NULL
specific	NULL
mutation	NULL
of	NULL
these	NULL
GATA	NULL
sites	NULL
resulted	NULL
in	NULL
virtual	NULL
abrogation	NULL
of	NULL
the	NULL
activation	NULL
by	NULL
hGATA-3	NULL
.	NULL

Further	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
hGATA-3	NULL
transcriptional	NULL
activation	NULL
domain	NULL
abolished	NULL
GATA-dependent	NULL
HIV-1	NULL
trans-activation	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
viral	NULL
transcription	NULL
observed	NULL
is	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
cotransfected	NULL
hGATA-3	NULL
.	NULL

Introduction	NULL
of	NULL
the	NULL
HIV-1	NULL
plasmids	NULL
in	NULL
which	NULL
the	NULL
GATA	NULL
sites	NULL
have	NULL
been	NULL
mutated	NULL
into	NULL
human	NULL
T	NULL
lymphocytes	NULL
also	NULL
caused	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
LTR-mediated	NULL
transcription	NULL
at	NULL
both	NULL
the	NULL
basal	NULL
level	NULL
and	NULL
in	NULL
(	NULL
PHA-	NULL
plus	NULL
PMA-	NULL
)	NULL
stimulated	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
normal	NULL
role	NULL
in	NULL
T	NULL
lymphocyte	NULL
gene	NULL
regulation	NULL
,	NULL
hGATA-3	NULL
may	NULL
also	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
HIV-1	NULL
transcriptional	NULL
activation	NULL
.	NULL

INTRODUCTION	NULL
Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
the	NULL
etiologic	NULL
agent	NULL
of	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
,	NULL
and	NULL
infects	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
myelomonocytic	NULL
cells	NULL
using	NULL
the	NULL
CD4	NULL
receptor	NULL
for	NULL
viral	NULL
entry	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

The	NULL
retroviral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
of	NULL
HIV-1	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
play	NULL
a	NULL
number	NULL
of	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
life	NULL
cycle	NULL
of	NULL
the	NULL
virus	NULL
after	NULL
infection	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
LTR	NULL
U3	NULL
region	NULL
contains	NULL
a	NULL
variety	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
responsible	NULL
for	NULL
modulating	NULL
viral	NULL
gene	NULL
expression	NULL
and	NULL
was	NULL
initially	NULL
divided	NULL
into	NULL
the	NULL
basal	NULL
promoter	NULL
region	NULL
,	NULL
the	NULL
enhancer	NULL
(	NULL
Enh	NULL
)	NULL
,	NULL
the	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
NRE	NULL
)	NULL
and	NULL
the	NULL
downstream	NULL
regulatory	NULL
element	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Beginning	NULL
at	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
the	NULL
leader	NULL
binding	NULL
protein	NULL
(	NULL
LBP-1	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
three	NULL
sites	NULL
between	NULL
-17	NULL
and	NULL
+27	NULL
,	NULL
and	NULL
negatively	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
HIV-1	NULL
(	NULL
5	NULL
)	NULL
;	NULL
the	NULL
virally-encoded	NULL
regulatory	NULL
factor	NULL
tat	NULL
also	NULL
binds	NULL
to	NULL
this	NULL
same	NULL
region	NULL
in	NULL
both	NULL
DNA	NULL
and	NULL
RNA	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
minimal	NULL
promoter	NULL
contains	NULL
TATA	NULL
(	NULL
9	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
factor	NULL
binding	NULL
sites	NULL
responsible	NULL
for	NULL
basal	NULL
level	NULL
transcription	NULL
of	NULL
the	NULL
virus	NULL
.	NULL

The	NULL
enhancer	NULL
element	NULL
contains	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
NF-xB	NULL
(	NULL
12	NULL
)	NULL
,	NULL
a	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
which	NULL
becomes	NULL
post-translationally	NULL
induced	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
is	NULL
the	NULL
principal	NULL
cis-determinant	NULL
for	NULL
the	NULL
inducibility	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
T	NULL
cell	NULL
stimuli	NULL
.	NULL

Lying	NULL
further	NULL
5	NULL
'	NULL
from	NULL
the	NULL
HIV-1	NULL
CAP	NULL
site	NULL
is	NULL
the	NULL
NRE	NULL
region	NULL
,	NULL
which	NULL
suppresses	NULL
transcription	NULL
of	NULL
HIV-1	NULL
by	NULL
two-	NULL
to	NULL
three-fold	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
NRE	NULL
region	NULL
contains	NULL
recognition	NULL
sequences	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
three	NULL
AP-1	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
13	NULL
)	NULL
,	NULL
a	NULL
consensus	NULL
myb	NULL
binding	NULL
site	NULL
(	NULL
14	NULL
)	NULL
,	NULL
a	NULL
T	NULL
cell-specific	NULL
NFAT-1	NULL
binding	NULL
site	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
another	NULL
element	NULL
(	NULL
at	NULL
-	NULL
165	NULL
to	NULL
-175	NULL
)	NULL
which	NULL
closely	NULL
resembles	NULL
the	NULL
negatively	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
.	NULL

While	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
HIV-1	NULL
has	NULL
been	NULL
extensively	NULL
examined	NULL
,	NULL
the	NULL
precise	NULL
role	NULL
that	NULL
many	NULL
of	NULL
these	NULL
factors	NULL
may	NULL
play	NULL
in	NULL
the	NULL
basal	NULL
or	NULL
induced	NULL
levels	NULL
of	NULL
transcriptional	NULL
stimulation	NULL
from	NULL
HIV-1	NULL
remains	NULL
obscure	NULL
,	NULL
primarily	NULL
due	NULL
to	NULL
a	NULL
lack	NULL
of	NULL
direct	NULL
evidence	NULL
for	NULL
the	NULL
proposed	NULL
activity	NULL
of	NULL
these	NULL
factors	NULL
in	NULL
several	NULL
of	NULL
the	NULL
aforementioned	NULL
cases	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
only	NULL
cell	NULL
type-specific	NULL
transcription	NULL
factor	NULL
known	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
LTR	NULL
(	NULL
NFAT-1	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
not	NULL
to	NULL
participate	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
virus	NULL
(	NULL
45	NULL
)	NULL
.	NULL

We	NULL
nonetheless	NULL
anticipated	NULL
that	NULL
hematopoietic	NULL
cell-restricted	NULL
transcription	NULL
factors	NULL
might	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
HIV-1	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
T	NULL
lymphocyte	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
,	NULL
human	NULL
GATA-3	NULL
(	NULL
hGATA-3	NULL
)	NULL
,	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
multigene	NULL
family	NULL
which	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
GATA	NULL
DNA	NULL
sequence	NULL
motif	NULL
through	NULL
a	NULL
highly	NULL
conserved	NULL
C	NULL
,	NULL
zinc	NULL
finger	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

GATA-3	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
where	NULL
no	NULL
other	NULL
GATA	NULL
proteins	NULL
are	NULL
detectable	NULL
(	NULL
19	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
a	NULL
specific	NULL
subset	NULL
of	NULL
neurons	NULL
within	NULL
the	NULL
vertebrate	NULL
CNS	NULL
and	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
2832	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

12	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
,	NULL
20	NULL
)	NULL
,	NULL
and	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
amino	NULL
acid	NULL
sequence	NULL
identity	NULL
when	NULL
comparing	NULL
the	NULL
vertebrate	NULL
GATA-3	NULL
proteins	NULL
(	NULL
18	NULL
,	NULL
21	NULL
)	NULL
.	NULL

GATA-3	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptors	NULL
(	NULL
TCRs	NULL
;	NULL
22	NULL
,	NULL
23	NULL
,	NULL
24	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
GATA-3	NULL
sites	NULL
within	NULL
the	NULL
human	NULL
TCR	NULL
8	NULL
gene	NULL
enhancer	NULL
are	NULL
required	NULL
for	NULL
the	NULL
tissue-specific	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
(	NULL
18	NULL
,	NULL
27	NULL
)	NULL
.	NULL

On	NULL
inspection	NULL
of	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
domain	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
we	NULL
found	NULL
four	NULL
consensus	NULL
GATA	NULL
binding	NULL
sites	NULL
(	NULL
WGATAR	NULL
;	NULL
28	NULL
)	NULL
,	NULL
and	NULL
therefore	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
hGATA-3	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
regulating	NULL
transcription	NULL
of	NULL
the	NULL
virus	NULL
.	NULL

hGATA-3	NULL
was	NULL
found	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
four	NULL
anticipated	NULL
GATA	NULL
sites	NULL
,	NULL
but	NULL
in	NULL
addition	NULL
,	NULL
strongly	NULL
bound	NULL
in	NULL
vitro	NULL
to	NULL
two	NULL
other	NULL
non-consensus	NULL
sites	NULL
.	NULL

Mutation	NULL
of	NULL
all	NULL
sites	NULL
resulted	NULL
in	NULL
much	NULL
lower	NULL
activation	NULL
of	NULL
the	NULL
virus	NULL
upon	NULL
transfection	NULL
into	NULL
T	NULL
lymphocytes	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
the	NULL
hGATA-3	NULL
protein	NULL
by	NULL
introduction	NULL
of	NULL
mutations	NULL
into	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
hGATA-3	NULL
transcriptional	NULL
activation	NULL
domain	NULL
;	NULL
while	NULL
the	NULL
mutant	NULL
factor	NULL
binds	NULL
to	NULL
DNA	NULL
indistinguishably	NULL
from	NULL
the	NULL
wild	NULL
type	NULL
hGATA-3	NULL
protein	NULL
,	NULL
it	NULL
no	NULL
longer	NULL
stimulates	NULL
HIV-1	NULL
LTR-directed	NULL
transcription	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
transcription	NULL
factor	NULL
hGATA-3	NULL
contributes	NULL
to	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
DNA	NULL
binding	NULL
assays	NULL
10	NULL
ug	NULL
of	NULL
RSV/hGATA-3	NULL
cDNA	NULL
was	NULL
transfected	NULL
into	NULL
QT6	NULL
quail	NULL
fibroblast	NULL
cells	NULL
using	NULL
CaPO	NULL
,	NULL
(	NULL
detailed	NULL
below	NULL
)	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
48	NULL
hours	NULL
after	NULL
transfection	NULL
(	NULL
29	NULL
)	NULL
;	NULL
QT6	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
expression	NULL
of	NULL
GATA	NULL
proteins	NULL
,	NULL
since	NULL
they	NULL
lack	NULL
discernible	NULL
GATA	NULL
binding	NULL
activities	NULL
(	NULL
17	NULL
and	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
then	NULL
partially	NULL
purified	NULL
for	NULL
total	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
passing	NULL
through	NULL
,	NULL
and	NULL
high	NULL
salt	NULL
elution	NULL
from	NULL
,	NULL
a	NULL
double	NULL
stranded	NULL
calf	NULL
thymus	NULL
DNA	NULL
column	NULL
and	NULL
pooling	NULL
the	NULL
bound	NULL
fractions	NULL
(	NULL
30	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
this	NULL
partially	NULL
purified	NULL
hGATA-3	NULL
protein	NULL
with	NULL
either	NULL
coding	NULL
or	NULL
non-coding	NULL
strand	NULL
end-labeled	NULL
HIV-1	NULL
LTR	NULL
DNA	NULL
(	NULL
30	NULL
)	NULL
.	NULL

For	NULL
electrophoretic	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EGMSA	NULL
)	NULL
,	NULL
whole-cell	NULL
extracts	NULL
prepared	NULL
as	NULL
above	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
oligonucleotide	NULL
T	NULL
&	NULL
SE4	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
GATA	NULL
sequences	NULL
within	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
6	NULL
gene	NULL
enhancer	NULL
footprint	NULL
4	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

PCR	NULL
mutagenesis	NULL
The	NULL
primers	NULL
used	NULL
in	NULL
these	NULL
PCR	NULL
assays	NULL
(	NULL
each	NULL
of	NULL
which	NULL
contain	NULL
additional	NULL
nucleotides	NULL
outside	NULL
of	NULL
the	NULL
restriction	NULL
site	NULL
for	NULL
convenience	NULL
of	NULL
subsequent	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
each	NULL
GATA	NULL
binding	NULL
site	NULL
(	NULL
determined	NULL
in	NULL
the	NULL
footprinting	NULL
assays	NULL
,	NULL
above	NULL
)	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
was	NULL
independently	NULL
generated	NULL
by	NULL
PCR	NULL
mutagenesis	NULL
into	NULL
the	NULL
corresponding	NULL
restriction	NULL
enzyme	NULL
site	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

DNA	NULL
sequences	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
to	NULL
the	NULL
target	NULL
GATA	NULL
site	NULL
were	NULL
amplified	NULL
separately	NULL
,	NULL
digested	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
enzyme	NULL
,	NULL
and	NULL
ligated	NULL
into	NULL
pCAT-basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Further	NULL
mutations	NULL
were	NULL
introduced	NULL
by	NULL
repeating	NULL
the	NULL
procedure	NULL
until	NULL
all	NULL
of	NULL
the	NULL
individual	NULL
GATA	NULL
site	NULL
mutations	NULL
were	NULL
incorporated	NULL
into	NULL
the	NULL
noGATA/CAT	NULL
plasmid	NULL
.	NULL

Since	NULL
sequences	NULL
5	NULL
to	NULL
GATA	NULL
binding	NULL
site	NULL
5	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
were	NULL
found	NULL
to	NULL
not	NULL
influence	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
4	NULL
,	NULL
31	NULL
)	NULL
,	NULL
both	NULL
HIV	NULL
and	NULL
the	NULL
noGATA/CAT	NULL
test	NULL
plasmids	NULL
extend	NULL
to	NULL
nucleotide	NULL
-376	NULL
relative	NULL
to	NULL
the	NULL
mRNA	NULL
CAP	NULL
site	NULL
.	NULL

A	NULL
mutation	NULL
which	NULL
specifically	NULL
abolishes	NULL
all	NULL
trans-activation	NULL
activity	NULL
within	NULL
the	NULL
hGATA-3	NULL
protein	NULL
coding	NULL
sequence	NULL
was	NULL
generated	NULL
by	NULL
removing	NULL
an	NULL
internal	NULL
Smal	NULL
fragment	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
hGATA-3	NULL
plasmid	NULL
(	NULL
called	NULL
d29-128	NULL
)	NULL
specifically	NULL
deletes	NULL
,	NULL
in	NULL
frame	NULL
,	NULL
amino	NULL
acids	NULL
29	NULL
to	NULL
128	NULL
of	NULL
the	NULL
hGATA-3	NULL
protein	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
mutant	NULL
d29-128	NULL
protein	NULL
binds	NULL
to	NULL
DNA	NULL
in	NULL
a	NULL
manner	NULL
indistinguishable	NULL
from	NULL
wild-type	NULL
hGATA-3	NULL
.	NULL

Transfections	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
procedure	NULL
(	NULL
32	NULL
)	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
or	NULL
mutated	NULL
HIV-1	NULL
LTR	NULL
constructs	NULL
plus	NULL
5	NULL
ug	NULL
of	NULL
RSV/AGATA-3	NULL
(	NULL
18	NULL
)	NULL
.	NULL

40	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
from	NULL
a	NULL
confluent	NULL
plate	NULL
were	NULL
used	NULL
for	NULL
each	NULL
transfection	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
48	NULL
hours	NULL
after	NULL
transfection	NULL
by	NULL
the	NULL
freeze/thaw	NULL
procedure	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
aliquots	NULL
of	NULL
extract	NULL
containing	NULL
equal	NULL
quantities	NULL
of	NULL
recovered	NULL
protein	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
result	NULL
was	NULL
quantified	NULL
by	NULL
determining	NULL
the	NULL
amount	NULL
of	NULL
acetylated	NULL
[	NULL
!	NULL

4C	NULL
]	NULL
chloramphenicol	NULL
produced	NULL
in	NULL
the	NULL
enzymatic	NULL
assay	NULL
and	NULL
the	NULL
degree	NULL
of	NULL
conversion	NULL
was	NULL
quantitated	NULL
on	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
HIV-1	NULL
LTR	NULL
constructs	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
35	NULL
)	NULL
.	NULL

100	NULL
ng	NULL
of	NULL
RSV/luciferase	NULL
was	NULL
also	NULL
added	NULL
as	NULL
a	NULL
transfection	NULL
efficiency	NULL
control	NULL
.	NULL

Half	NULL
of	NULL
the	NULL
cells	NULL
from	NULL
each	NULL
transfection	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
nM	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
Sigma	NULL
)	NULL
plus	NULL
2	NULL
ug/ml	NULL
phytoheamagglutinnin	NULL
(	NULL
PHA	NULL
;	NULL
Sigma	NULL
)	NULL
for	NULL
the	NULL
last	NULL
20	NULL
hours	NULL
in	NULL
order	NULL
to	NULL
activate	NULL
the	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
44	NULL
hours	NULL
after	NULL
transfection	NULL
and	NULL
luciferase	NULL
expression	NULL
was	NULL
quantitated	NULL
with	NULL
a	NULL
luminometer	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
normalized	NULL
using	NULL
an	NULL
amount	NULL
of	NULL
extract	NULL
containing	NULL
equal	NULL
luciferase	NULL
activity	NULL
.	NULL

All	NULL
cell	NULL
transfection	NULL
or	NULL
cotransfection	NULL
experiments	NULL
reported	NULL
here	NULL
were	NULL
performed	NULL
on	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
occasions	NULL
,	NULL
often	NULL
using	NULL
different	NULL
plasmid	NULL
preparations	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
one	NULL
s.d	NULL
.	NULL

from	NULL
these	NULL
accumulated	NULL
assays	NULL
.	NULL

RESULTS	NULL
hGATA-3	NULL
binds	NULL
in	NULL
vitro	NULL
to	NULL
six	NULL
sites	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
Since	NULL
the	NULL
expression	NULL
profile	NULL
of	NULL
hGATA-3	NULL
is	NULL
partially	NULL
consistent	NULL
with	NULL
the	NULL
documented	NULL
tropism	NULL
of	NULL
HIV-1	NULL
replication	NULL
,	NULL
one	NULL
might	NULL
anticipate	NULL
that	NULL
hGATA-3	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
T	NULL
lymphocyte	NULL
expression	NULL
of	NULL
HIV-1	NULL
.	NULL

Initial	NULL
inspection	NULL
of	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
viral	NULL
LTR	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
four	NULL
potential	NULL
GATA	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

Both	NULL
strands	NULL
of	NULL
HIV-1	NULL
U3	NULL
region	NULL
DNA	NULL
were	NULL
examined	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
hGATA-3	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
using	NULL
partially	NULL
purified	NULL
hGATA-3	NULL
protein	NULL
expressed	NULL
in	NULL
,	NULL
and	NULL
partially	NULL
purified	NULL
from	NULL
,	NULL
animal	NULL
cells	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
;	NULL
as	NULL
also	NULL
shown	NULL
in	NULL
Figure	NULL
2C	NULL
,	NULL
no	NULL
GATA	NULL
binding	NULL
activity	NULL
is	NULL
normally	NULL
detected	NULL
in	NULL
QT6	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
results	NULL
actually	NULL
revealed	NULL
six	NULL
hGATA-3	NULL
interaction	NULL
sites	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
,	NULL
all	NULL
localized	NULL
within	NULL
the	NULL
5	NULL
domain	NULL
of	NULL
the	NULL
LTR	NULL
.	NULL

The	NULL
four	NULL
consensus	NULL
GATA	NULL
sites	NULL
(	NULL
28	NULL
)	NULL
were	NULL
protected	NULL
by	NULL
hGATA-3	NULL
,	NULL
as	NULL
were	NULL
two	NULL
non-canonical	NULL
binding	NULL
sites	NULL
:	NULL
GATTA	NULL
(	NULL
site	NULL
5	NULL
)	NULL
and	NULL
GATGA	NULL
(	NULL
site	NULL
2	NULL
;	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
site	NULL
overlaps	NULL
a	NULL
previously	NULL
defined	NULL
binding	NULL
site	NULL
for	NULL
a	NULL
50	NULL
kD	NULL
negative	NULL
regulatory	NULL
protein	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
for	NULL
binding	NULL
of	NULL
hGATA-3	NULL
to	NULL
these	NULL
sites	NULL
was	NULL
confirmed	NULL
in	NULL
competition	NULL
experiments	NULL
.	NULL

When	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
high	NULL
affinity	NULL
GATA	NULL
oligonucleotide	NULL
TSE4	NULL
(	NULL
from	NULL
the	NULL
human	NULL
TCR	NULL
8	NULL
gene	NULL
enhancer	NULL
;	NULL
18	NULL
,	NULL
27	NULL
)	NULL
is	NULL
included	NULL
in	NULL
the	NULL
Table	NULL
1	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
HIV-1	NULL
PCR-directed	NULL
site	NULL
specific	NULL
mutagenesis	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

12	NULL
2833	NULL
Oligonucleotide	NULL
DNA	NULL
sequence	NULL
Corresponds	NULL
to	NULL
nt*	NULL
5	NULL
'	NULL
CGAT	NULL
AAGCT	NULL
TGGAA	NULL
GGGCT	NULL
AATTC	NULL
ACT	NULL
-453	NULL
to	NULL
-436	NULL
3	NULL
'	NULL
GCT	NULL
TTCTA	NULL
GAGGC	NULL
TTAAG	NULL
CAGT	NULL
+71	NULL
to	NULL
+60	NULL
site	NULL
1	NULL
,	NULL
5	NULL
``	NULL
CACT	NULL
GCATG	NULL
CGAGC	NULL
TTGCT	NULL
ACAA	NULL
-118	NULL
to	NULL
'-105	NULL
site	NULL
1	NULL
,	NULL
3	NULL
'	NULL
GCTC	NULL
GCATG	NULL
CAGCA	NULL
GTTCT	NULL
TGAA	NULL
-122	NULL
to	NULL
-136	NULL
site	NULL
2	NULL
,	NULL
5	NULL
'	NULL
ATT	NULL
TGTCG	NULL
ACGTG	NULL
GCCCG	NULL
AGA	NULL
-165	NULL
to	NULL
-153	NULL
site	NULL
2	NULL
,	NULL
3	NULL
``	NULL
CACG	NULL
TCGAC	NULL
AAATG	NULL
CTAGG	NULL
CGGC	NULL
-170	NULL
to	NULL
-183	NULL
site	NULL
3	NULL
,	NULL
5	NULL
'	NULL
TCC	NULL
ACTCG	NULL
AGGTA	NULL
GAGAG	NULL
GCCA	NULL
-288	NULL
to	NULL
-274	NULL
site	NULL
3	NULL
,	NULL
3	NULL
'	NULL
CTACC	NULL
TCGAG	NULL
TGGCT	NULL
CAACT	NULL
GGTA	NULL
-292	NULL
to	NULL
-306	NULL
site	NULL
4	NULL
,	NULL
5	NULL
``	NULL
ATC	NULL
AGAGC	NULL
TCCAC	NULL
TGACC	NULL
TTTGG	NULL
-338	NULL
to	NULL
-324	NULL
site	NULL
4	NULL
,	NULL
3	NULL
'	NULL
AGT	NULL
GGAGC	NULL
TCTGA	NULL
CCCCT	NULL
GG	NULL
-341	NULL
to	NULL
-352	NULL
site	NULL
5	NULL
,	NULL
5	NULL
'	NULL
TTCCC	NULL
TGCAG	NULL
AGCAG	NULL
AACTA	NULL
CAC	NULL
-372	NULL
to	NULL
-306	NULL
site	NULL
5	NULL
,	NULL
3	NULL
'	NULL
TG	NULL
CTCTG	NULL
CAGGG	NULL
AAGTA	NULL
GCC	NULL
-376	NULL
to	NULL
-388	NULL
*Nucleotide	NULL
numbering	NULL
shown	NULL
is	NULL
for	NULL
the	NULL
bold	NULL
nucleotides	NULL
in	NULL
the	NULL
center	NULL
column	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
HIV-1	NULL
LTR	NULL
sequence	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

Nucleotides	NULL
shown	NULL
in	NULL
normal	NULL
lettering	NULL
(	NULL
on	NULL
the	NULL
left	NULL
;	NULL
the	NULL
5	NULL
'	NULL
end	NULL
in	NULL
each	NULL
case	NULL
)	NULL
were	NULL
used	NULL
to	NULL
substitute	NULL
restriction	NULL
enzyme	NULL
sites	NULL
for	NULL
hGATA-3	NULL
binding	NULL
sites	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
2B	NULL
.	NULL

footprinting	NULL
reactions	NULL
,	NULL
the	NULL
protein	NULL
:	NULL
DNA	NULL
complex	NULL
at	NULL
each	NULL
of	NULL
the	NULL
six	NULL
sites	NULL
is	NULL
disrupted	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
hGATA-3	NULL
binds	NULL
to	NULL
six	NULL
specific	NULL
sites	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
transcriptional	NULL
regulatory	NULL
domain	NULL
.	NULL

hGATA-3	NULL
trans-activates	NULL
HIV-1	NULL
LTR-mediated	NULL
transcription	NULL
We	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
hGATA-3	NULL
might	NULL
trans-activate	NULL
HIV-1	NULL
LTR-mediated	NULL
transcription	NULL
by	NULL
cotransfection	NULL
experiments	NULL
using	NULL
a	NULL
reporter	NULL
gene	NULL
whose	NULL
activity	NULL
was	NULL
transcriptionally	NULL
directed	NULL
by	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

We	NULL
initially	NULL
examined	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
plasmid	NULL
(	NULL
and	NULL
derivatives	NULL
)	NULL
after	NULL
transfection	NULL
into	NULL
HeLa	NULL
cells	NULL
,	NULL
where	NULL
only	NULL
low	NULL
levels	NULL
of	NULL
hGATA-2	NULL
,	NULL
and	NULL
no	NULL
hGATA-1	NULL
or	NULL
hGATA-3	NULL
,	NULL
is	NULL
expressed	NULL
.	NULL

The	NULL
HIV-1	NULL
LTR	NULL
(	NULL
nucleotides	NULL
-376	NULL
to	NULL
+80	NULL
,	NULL
Figure	NULL
1A	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
a	NULL
promoterless	NULL
reporter	NULL
vector	NULL
to	NULL
generate	NULL
HIV	NULL
this	NULL
construct	NULL
was	NULL
cotransfected	NULL
into	NULL
HeLa	NULL
cells	NULL
with	NULL
an	NULL
activator	NULL
plasmid	NULL
constitutively	NULL
expressing	NULL
the	NULL
hGATA-3	NULL
protein	NULL
(	NULL
RSV/hGATA-3	NULL
;	NULL
18	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
hGATA-3	NULL
indeed	NULL
stimulates	NULL
HIVWwt/CAT	NULL
expression	NULL
by	NULL
an	NULL
average	NULL
of	NULL
seven-fold	NULL
upon	NULL
cotransfection	NULL
into	NULL
HeLa	NULL
cells	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
repeating	NULL
the	NULL
same	NULL
experiments	NULL
in	NULL
QT6	NULL
cells	NULL
,	NULL
thereby	NULL
demonstrating	NULL
that	NULL
the	NULL
stimulatory	NULL
effect	NULL
detected	NULL
in	NULL
non-T	NULL
cells	NULL
is	NULL
dependent	NULL
only	NULL
upon	NULL
cotransfected	NULL
hGATA-3	NULL
activator	NULL
plasmid	NULL
(	NULL
31	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
hGATA-3	NULL
is	NULL
capable	NULL
of	NULL
stimulating	NULL
HIV-1	NULL
transcription	NULL
in	NULL
vertebrate	NULL
cells	NULL
which	NULL
express	NULL
little	NULL
endogenous	NULL
GATA	NULL
factor	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
expression	NULL
of	NULL
HIVWt/CAT	NULL
was	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
coexpressing	NULL
functional	NULL
hGATA-3	NULL
protein	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
,	NULL
a	NULL
deletion	NULL
of	NULL
amino	NULL
acids	NULL
29	NULL
to	NULL
128	NULL
(	NULL
which	NULL
abrogates	NULL
the	NULL
trans-activation	NULL
ability	NULL
of	NULL
the	NULL
factor	NULL
;	NULL
36	NULL
)	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
hGATA-3	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
the	NULL
mutant	NULL
hGATA-3	NULL
protein	NULL
no	NULL
longer	NULL
trans-activates	NULL
HIV	NULL
transcription	NULL
,	NULL
although	NULL
the	NULL
mutant	NULL
protein	NULL
binds	NULL
to	NULL
a	NULL
GATA	NULL
oligonucleotide	NULL
in	NULL
EGMSA	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
and	NULL
stably	NULL
accumulates	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
as	NULL
confirmed	NULL
by	NULL
western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-hGATA-3	NULL
monoclonal	NULL
antibody	NULL
;	NULL
36	NULL
)	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
a	NULL
fully	NULL
functional	NULL
hGATA-3	NULL
factor	NULL
is	NULL
required	NULL
for	NULL
trans-activation	NULL
of	NULL
HIV-1-directed	NULL
expression	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
increase	NULL
in	NULL
expression	NULL
was	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
hGATA-3	NULL
binding	NULL
to	NULL
the	NULL
identified	NULL
GATA	NULL
sites	NULL
within	NULL
the	NULL
LTR	NULL
of	NULL
HIV-1	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
a	NULL
series	NULL
of	NULL
mutations	NULL
were	NULL
generated	NULL
in	NULL
the	NULL
LTR	NULL
where	NULL
the	NULL
GATA	NULL
sequences	NULL
(	NULL
arbitrarily	NULL
numbered	NULL
1	NULL
to	NULL
6	NULL
;	NULL
Figure	NULL
1	NULL
)	NULL
were	NULL
individually	NULL
changed	NULL
into	NULL
unique	NULL
restriction	NULL
enzyme	NULL
recognition	NULL
sites	NULL
and	NULL
then	NULL
ligated	NULL
into	NULL
a	NULL
single	NULL
HIV-1	NULL
6	NULL
~453	NULL
TGG	NULL
AAGGGCTAAT	NULL
TCACTCCCAA	NULL
CGAAGACAA®	NULL
A®A®CcrTca	NULL
§	NULL
-410	NULL
-	NULL
TCTGTGGATC	NULL
TACCACACAC	NULL
AAGGCTACTT	NULL
CAGAACTACA	NULL
CACCAGGGCC	NULL
ACGGGTCAGA	NULL
AP-1	NULL
a	NULL
coach	NULL
3	NULL
~340	NULL
-	NULL
PARCCACTGA	NULL
_CCTTTGGATG	NULL
GTGCTACAAG	NULL
CTAGTACCAG	NULL
TPGAGCCAGA	NULL
GAGGCCAATA	NULL
AP-A	NULL
AP-1	NULL
~270	NULL
AMGGAGAGAA	NULL
CACCMGCTTG	NULL
TTACACCCTG	NULL
TGAGCCTGCA	NULL
TGGGATGGAT	NULL
GACCCGGAGA	NULL
GAGAAGTGTT	NULL
FAT	NULL
a	NULL
-200	NULL
-	NULL
AGRGTGGAGG	NULL
TTTGACAGCC	NULL
GCCTAGCATE	NULL
ccocomsase	NULL
TecaTccosa	NULL
GTacTTcaas	NULL
TL-2	NULL
NRB	NULL
i	NULL
~130	NULL
|	NULL
AACTGCT	NULL
@	NULL
A®	NULL
ATCGAGCTTG	NULL
CTACAAGGGA	NULL
CTTTCcGCTe	NULL
GoGacrrce	NULL
AcGGacoca®	NULL
we-xs	NULL
wr-ks	NULL
Spi	NULL
Sp1	NULL
-60	NULL
.	NULL

gTooceasee	NULL
CTCAGATCCT	NULL
GCATATAAGC	NULL
AGCTGcTTrr	NULL
TeccrGract	NULL
Sp1	NULL
TriiD	NULL
«	NULL
L	NULL
Mem	NULL
Lak	NULL
1	NULL
Site	NULL
:	NULL
6	NULL
§	NULL
4	NULL
3	NULL
2	NULL
1	NULL
.	NULL

AAGATATCCTT	NULL
...	NULL
CTGATTAGC	NULL
...	NULL
CAGATATCCA	NULL
...	NULL
CAGATAAG	NULL
...	NULL
TTTCATCAC	NULL
...	NULL
GCTGATATCG	NULL
.	NULL

AAGTCGACCTT	NULL
...	NULL
.CTGCAGAGC	NULL
..	NULL
TCAGAGCTCCA	NULL
...	NULL
CACTCGAG	NULL
...	NULL
.TTAGTAGTC	NULL
...	NULL
.GCTGGATGCG..	NULL
(	NULL
Acch	NULL
(	NULL
Pst	NULL
)	NULL
(	NULL
Sach	NULL
(	NULL
Xhol	NULL
)	NULL
(	NULL
Sail	NULL
Figure	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
.	NULL

Transcription	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
44	NULL
)	NULL
from	NULL
the	NULL
CAP	NULL
site	NULL
(	NULL
nucleotide	NULL
+1	NULL
)	NULL
extending	NULL
5	NULL
'	NULL
to	NULL
the	NULL
boundary	NULL
of	NULL
the	NULL
U3	NULL
region	NULL
is	NULL
shown	NULL
.	NULL

Consensus	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
underlined	NULL
and	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
corresponding	NULL
DNA	NULL
binding	NULL
proteins	NULL
are	NULL
shown	NULL
either	NULL
below	NULL
or	NULL
above	NULL
the	NULL
sequence	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
sites	NULL
for	NULL
hGATA-3	NULL
identified	NULL
by	NULL
in	NULL
vitro	NULL
footprinting	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
outlined	NULL
letters	NULL
and	NULL
are	NULL
numbered	NULL
1	NULL
to	NULL
6	NULL
consecutively	NULL
,	NULL
beginning	NULL
closest	NULL
to	NULL
the	NULL
HIV-1	NULL
CAP	NULL
site	NULL
.	NULL

The	NULL
numbers	NULL
at	NULL
the	NULL
left	NULL
indicate	NULL
the	NULL
nucleotide	NULL
number	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

(	NULL
B	NULL
)	NULL
.	NULL

GATA	NULL
binding	NULL
sites	NULL
and	NULL
their	NULL
mutations	NULL
.	NULL

All	NULL
six	NULL
hGATA-3	NULL
binding	NULL
sites	NULL
and	NULL
ing	NULL
sequences	NULL
are	NULL
listed	NULL
on	NULL
the	NULL
top	NULL
line	NULL
with	NULL
the	NULL
GATA	NULL
sequence	NULL
shown	NULL
in	NULL
bold	NULL
.	NULL

Each	NULL
GATA	NULL
site	NULL
was	NULL
mutated	NULL
to	NULL
a	NULL
specific	NULL
restriction	NULL
enzyme	NULL
site	NULL
by	NULL
PCR	NULL
mutagenesis	NULL
(	NULL
underlined	NULL
)	NULL
as	NULL
shown	NULL
on	NULL
the	NULL
bottom	NULL
line	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

LTR	NULL
(	NULL
called	NULL
noGATA	NULL
;	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
confirmed	NULL
that	NULL
the	NULL
mutations	NULL
indeed	NULL
eliminated	NULL
hGATA-3	NULL
binding	NULL
to	NULL
the	NULL
GATA	NULL
sites	NULL
identified	NULL
in	NULL
the	NULL
footprinting	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
individual	NULL
and	NULL
multiple	NULL
GATA	NULL
binding	NULL
site	NULL
mutations	NULL
were	NULL
next	NULL
functionally	NULL
analyzed	NULL
for	NULL
their	NULL
effect	NULL
upon	NULL
the	NULL
ability	NULL
of	NULL
hGATA-3	NULL
to	NULL
direct	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Mutagenesis	NULL
of	NULL
individual	NULL
GATA	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
site	NULL
2	NULL
(	NULL
within	NULL
the	NULL
NRE	NULL
;	NULL
4	NULL
)	NULL
,	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
slight	NULL
diminution	NULL
in	NULL
the	NULL
transcriptional	NULL
stimulation	NULL
of	NULL
the	NULL
LTR	NULL
by	NULL
hGATA-3	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
all	NULL
of	NULL
the	NULL
mutations	NULL
were	NULL
combined	NULL
into	NULL
a	NULL
single	NULL
2834	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

12	NULL
o	NULL
o	NULL
HR	NULL
«	NULL
he	NULL
:	NULL
a	NULL
8	NULL
8	NULL
$	NULL
4	NULL
}	NULL
toh	NULL
|	NULL
|	NULL
&	NULL
s	NULL
TIRE	NULL
im	NULL
um	NULL
=e	NULL
um	NULL
``	NULL
~	NULL
,	NULL
«	NULL
w	NULL
#	NULL
=	NULL
§	NULL
-	NULL
k	NULL
-	NULL
§	NULL
&	NULL
a*	NULL
ae	NULL
#	NULL
«	NULL
-	NULL
«	NULL
-	NULL
din	NULL
«	NULL
«	NULL
i	NULL
stile	NULL
.	NULL

wiih	NULL
-	NULL
Olsson	NULL
AA	NULL
.	NULL

a	NULL
@	NULL
«	NULL
-	NULL
@	NULL
#	NULL
sagwg	NULL
ii	NULL
jog	NULL
VVVV	NULL
s	NULL
®	NULL
®	NULL
am	NULL
us	NULL
-	NULL
We	NULL
t	NULL
dis	NULL
Pes	NULL
f	NULL
pes	NULL
29g	NULL
min-	NULL
«	NULL
ugun	NULL
as	NULL
*	NULL
¥	NULL
&	NULL
-	NULL
#	NULL
is	NULL
as	NULL
l	NULL
|	NULL
%	NULL
as	NULL
=	NULL
<	NULL
x	NULL
»	NULL
an	NULL
@	NULL
»	NULL
db	NULL
«	NULL
»	NULL
as	NULL
«	NULL
»	NULL
``	NULL
Cg	NULL
@	NULL
-	NULL
*-*	NULL
@	NULL
I	NULL
at	NULL
ath	NULL
ase	NULL
lik	NULL
us	NULL
aes	NULL
ies	NULL
e	NULL
``	NULL
&	NULL
&	NULL
-	NULL
:	NULL
-	NULL
%	NULL
«	NULL
o	NULL
«	NULL
P	NULL
t	NULL
ah	NULL
a	NULL
C	NULL
``	NULL
``	NULL
``	NULL
*	NULL
#	NULL
®	NULL
f	NULL
an	NULL
am	NULL
am	NULL
a	NULL
»	NULL
db	NULL
4b	NULL
me	NULL
R	NULL
<	NULL
in	NULL
dites	NULL
.	NULL

At	NULL
:	NULL
C	NULL
®	NULL
Figure	NULL
2.	NULL
hGATA-3	NULL
binding	NULL
to	NULL
the	NULL
HIV-1	NULL
wild	NULL
type	NULL
and	NULL
mutated	NULL
LTRs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
.	NULL

Footprinting	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
HIV-1	NULL
LTR	NULL
U3	NULL
region	NULL
.	NULL

Lanes	NULL
a-e	NULL
and	NULL
f-j	NULL
show	NULL
in	NULL
vitro	NULL
footprinting	NULL
reactions	NULL
of	NULL
the	NULL
coding	NULL
and	NULL
non-coding	NULL
strands	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
HIV-1	NULL
LTR	NULL
,	NULL
respectively	NULL
.	NULL

Lanes	NULL
a	NULL
,	NULL
f	NULL
:	NULL
no	NULL
protein	NULL
added	NULL
;	NULL
lanes	NULL
b	NULL
,	NULL
g	NULL
;	NULL
c	NULL
,	NULL
h	NULL
;	NULL
and	NULL
d	NULL
,	NULL
i	NULL
contain	NULL
1	NULL
al	NULL
,	NULL
3	NULL
gl	NULL
,	NULL
or	NULL
10	NULL
gl	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
partially	NULL
purified	NULL
hGATA-3	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Lanes	NULL
e	NULL
and	NULL
j	NULL
contain	NULL
3	NULL
al	NULL
of	NULL
hGATA-3	NULL
plus	NULL
50	NULL
ng	NULL
of	NULL
unlabeled	NULL
MaP	NULL
GATA	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
competitor	NULL
(	NULL
17	NULL
,	NULL
29	NULL
)	NULL
.	NULL

GATA-3-specific	NULL
footprints	NULL
1-6	NULL
are	NULL
indicated	NULL
by	NULL
boxes	NULL
shown	NULL
to	NULL
the	NULL
left	NULL
on	NULL
the	NULL
diagram	NULL
,	NULL
adjacent	NULL
to	NULL
each	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
coding	NULL
strand	NULL
,	NULL
and	NULL
on	NULL
the	NULL
right	NULL
for	NULL
the	NULL
non-coding	NULL
strand	NULL
.	NULL

(	NULL
B	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
GATA	NULL
sites	NULL
eliminates	NULL
hGATA-3	NULL
binding	NULL
.	NULL

Lanes	NULL
a	NULL
,	NULL
b	NULL
;	NULL
c	NULL
,	NULL
d	NULL
;	NULL
e	NULL
,	NULL
f	NULL
;	NULL
g	NULL
,	NULL
h	NULL
and	NULL
i	NULL
,	NULL
j	NULL
show	NULL
the	NULL
in	NULL
vitro	NULL
footprints	NULL
obtained	NULL
on	NULL
the	NULL
wild	NULL
type	NULL
HIV-1	NULL
LTR	NULL
,	NULL
or	NULL
on	NULL
LTRs	NULL
reconstructed	NULL
with	NULL
mutated	NULL
GATA	NULL
footprints	NULL
1-	NULL
,	NULL
3-	NULL
,	NULL
4-	NULL
or	NULL
5-	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
first	NULL
lane	NULL
of	NULL
each	NULL
pair	NULL
(	NULL
a	NULL
,	NULL
c	NULL
,	NULL
e	NULL
,	NULL
g	NULL
and	NULL
i	NULL
)	NULL
represent	NULL
footprints	NULL
without	NULL
added	NULL
protein	NULL
(	NULL
as	NULL
negative	NULL
controls	NULL
for	NULL
each	NULL
mutation	NULL
)	NULL
,	NULL
and	NULL
the	NULL
second	NULL
(	NULL
b	NULL
,	NULL
d	NULL
,	NULL
f	NULL
,	NULL
h	NULL
and	NULL
j	NULL
)	NULL
is	NULL
with	NULL
1	NULL
gl	NULL
of	NULL
partially	NULL
purified	NULL
hGATA-3	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

The	NULL
binding	NULL
to	NULL
mutated	NULL
GATA	NULL
site	NULL
2	NULL
was	NULL
abolished	NULL
when	NULL
examined	NULL
in	NULL
gel	NULL
shift	NULL
assay	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
numbers	NULL
at	NULL
left	NULL
indicate	NULL
GAT	NULL
A-3	NULL
footprints	NULL
1	NULL
to	NULL
6	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
.	NULL

Transcriptional	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
is	NULL
due	NULL
to	NULL
exogenous	NULL
hGATA-3	NULL
protein	NULL
.	NULL

QT6	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
HIVwt/CAT	NULL
and	NULL
antisense	NULL
or	NULL
sense	NULL
RSV/RGATA-3	NULL
DNA	NULL
or	NULL
mutant	NULL
RSV/hGATA-3	NULL
429-128	NULL
(	NULL
Materials	NULL
and	NULL
methods	NULL
;	NULL
31	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
split	NULL
and	NULL
plated	NULL
on	NULL
two	NULL
separate	NULL
dishes	NULL
;	NULL
one	NULL
set	NULL
was	NULL
used	NULL
to	NULL
assay	NULL
HIV-1	NULL
LTR-directed	NULL
transcription	NULL
,	NULL
while	NULL
the	NULL
other	NULL
was	NULL
used	NULL
to	NULL
prepare	NULL
cellular	NULL
extracts	NULL
for	NULL
EGMSA	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
is	NULL
a	NULL
radiolabeled	NULL
TdE4	NULL
oligonucleotide	NULL
containing	NULL
two	NULL
GATA	NULL
binding	NULL
sites	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
hGATA-3	NULL
shifted	NULL
bands	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
by	NULL
arrows	NULL
.	NULL

Lane	NULL
1	NULL
is	NULL
labeled	NULL
oligonucleotide	NULL
alone	NULL
,	NULL
while	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
contain	NULL
an	NULL
additional	NULL
100	NULL
ng	NULL
of	NULL
unlabeled	NULL
TdE4	NULL
oligonucleotide	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
from	NULL
QT6	NULL
cells	NULL
transfected	NULL
with	NULL
RSV/hGATA-3	NULL
(	NULL
s	NULL
;	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
)	NULL
,	NULL
antisense	NULL
RSV/hGATA-3	NULL
(	NULL
as	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
RSV/hGATA-3	NULL
429-128	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
)	NULL
.	NULL

plasmid	NULL
(	NULL
noGATA/CAT	NULL
;	NULL
Figure	NULL
3C	NULL
)	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
LTR	NULL
to	NULL
be	NULL
trans-activated	NULL
by	NULL
cotransfected	NULL
hGATA-3	NULL
was	NULL
significantly	NULL
reduced	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
hGATA-3	NULL
stimulates	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
GATA	NULL
sites	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
U3	NULL
regulatory	NULL
region	NULL
.	NULL

hGATA-3	NULL
binding	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
expression	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
both	NULL
quiescent	NULL
and	NULL
induced	NULL
T	NULL
lymphocytes	NULL
We	NULL
next	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
this	NULL
T	NULL
cell-restricted	NULL
transcription	NULL
factor	NULL
in	NULL
regulating	NULL
HIV-1	NULL
expression	NULL
in	NULL
its	NULL
natural	NULL
environment	NULL
,	NULL
i.e	NULL
.	NULL

within	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
(	NULL
TCR	NULL
«	NULL
B+CD4+*	NULL
)	NULL
,	NULL
which	NULL
expresses	NULL
abundant	NULL
hGATA-3	NULL
(	NULL
18	NULL
)	NULL
,	NULL
was	NULL
transfected	NULL
with	NULL
the	NULL
HIVwt/CAT	NULL
and	NULL
the	NULL
noGATA/CAT	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
reporter	NULL
plasmids	NULL
.	NULL

As	NULL
do	NULL
circulating	NULL
T	NULL
cells	NULL
,	NULL
Jurkat	NULL
cells	NULL
require	NULL
two	NULL
external	NULL
stimuli	NULL
to	NULL
synthesize	NULL
maximal	NULL
amounts	NULL
of	NULL
lymphokine	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
T	NULL
lymphocytes	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
increased	NULL
levels	NULL
of	NULL
hGATA-3	NULL
transcription	NULL
(	NULL
38	NULL
)	NULL
.	NULL

After	NULL
transfection	NULL
of	NULL
the	NULL
various	NULL
HIV/CAT	NULL
plasmids	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
total	NULL
of	NULL
44	NULL
hours	NULL
,	NULL
including	NULL
treatment	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
for	NULL
the	NULL
final	NULL
20	NULL
hours	NULL
.	NULL

Transfection	NULL
of	NULL
either	NULL
HIVWt/CAT	NULL
or	NULL
noGATA/CAT	NULL
into	NULL
Jurkat	NULL
cells	NULL
reveals	NULL
a	NULL
10-fold	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
when	NULL
comparing	NULL
stimulated	NULL
to	NULL
untreated	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
,	NULL
even	NULL
though	NULL
the	NULL
overall	NULL
expression	NULL
is	NULL
significantly	NULL
reduced	NULL
in	NULL
both	NULL
resting	NULL
or	NULL
stimulated	NULL
cells	NULL
when	NULL
noGATA/CAT	NULL
is	NULL
compared	NULL
to	NULL
HIVwt/CAT	NULL
expression	NULL
.	NULL

Thus	NULL
hGATA-3	NULL
exerts	NULL
its	NULL
effect	NULL
(	NULL
s	NULL
)	NULL
in	NULL
activating	NULL
the	NULL
basal	NULL
transcriptional	NULL
apparatus	NULL
through	NULL
binding	NULL
to	NULL
the	NULL
GATA	NULL
sites	NULL
within	NULL
the	NULL
LTR	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
stimulation-independent	NULL
manner	NULL
,	NULL
rather	NULL
than	NULL
through	NULL
the	NULL
same	NULL
PHA	NULL
+	NULL
PMA	NULL
stimulatory	NULL
pathway	NULL
of	NULL
activation	NULL
which	NULL
induces	NULL
NF-xB	NULL
(	NULL
12	NULL
)	NULL
.	NULL

DISCUSSION	NULL
We	NULL
show	NULL
here	NULL
that	NULL
the	NULL
T	NULL
lymphocyte	NULL
transcription	NULL
factor	NULL
hGATA-3	NULL
binds	NULL
in	NULL
vitro	NULL
with	NULL
high	NULL
specificity	NULL
to	NULL
six	NULL
sites	NULL
within	NULL
the	NULL
LTR	NULL
of	NULL
HIV-1	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
and	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
hGATA-3	NULL
is	NULL
required	NULL
for	NULL
a	NULL
7-fold	NULL
increase	NULL
in	NULL
HIV-1	NULL
LTR-mediated	NULL
transcriptional	NULL
activation	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

A	NULL
mutated	NULL
hGATA-3	NULL
factor	NULL
,	NULL
missing	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
but	NULL
which	NULL
still	NULL
binds	NULL
to	NULL
the	NULL
GATA	NULL
sites	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
,	NULL
fails	NULL
to	NULL
trans-activate	NULL
HIV	NULL
expression	NULL
.	NULL

The	NULL
reduction	NULL
in	NULL
HIV-1	NULL
transcription	NULL
seen	NULL
upon	NULL
transfection	NULL
of	NULL
a	NULL
mutated	NULL
HIV-1	NULL
LTR	NULL
(	NULL
bearing	NULL
mutations	NULL
in	NULL
all	NULL
of	NULL
the	NULL
GATA	NULL
binding	NULL
sites	NULL
)	NULL
after	NULL
transfection	NULL
into	NULL
T	NULL
lymphocyte	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
strongly	NULL
supports	NULL
the	NULL
initial	NULL
hypothesis	NULL
that	NULL
hGATA-3	NULL
is	NULL
one	NULL
of	NULL
the	NULL
cellular	NULL
factors	NULL
mediating	NULL
viral	NULL
LTR-directed	NULL
transcription	NULL
.	NULL

Mutation	NULL
of	NULL
all	NULL
of	NULL
the	NULL
GATA	NULL
binding	NULL
sites	NULL
did	NULL
not	NULL
fully	NULL
abolish	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
U3	NULL
transcriptional	NULL
regulatory	NULL
domain	NULL
of	NULL
HIV-1	NULL
harbors	NULL
binding	NULL
sites	NULL
for	NULL
a	NULL
large	NULL
number	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
,	NULL
many	NULL
of	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
and	NULL
several	NULL
of	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
direct	NULL
transcriptional	NULL
effects	NULL
on	NULL
this	NULL
transcription	NULL
unit	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

It	NULL
could	NULL
therefore	NULL
be	NULL
inferred	NULL
that	NULL
hGATA-3	NULL
acts	NULL
in	NULL
synergy	NULL
with	NULL
other	NULL
cellular	NULL
factors	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
GATA	NULL
binding	NULL
sites	NULL
,	NULL
as	NULL
well	NULL
as	NULL
other	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
might	NULL
cause	NULL
a	NULL
more	NULL
severe	NULL
defect	NULL
in	NULL
transcription	NULL
than	NULL
mutation	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
any	NULL
of	NULL
these	NULL
individual	NULL
sites	NULL
.	NULL

A	NULL
previous	NULL
analysis	NULL
of	NULL
the	NULL
element	NULL
within	NULL
the	NULL
HIV-1	NULL
LTR	NULL
bearing	NULL
homology	NULL
to	NULL
the	NULL
IL-2	NULL
NRE	NULL
identified	NULL
a	NULL
relatively	NULL
abundant	NULL
T	NULL
cell-restricted	NULL
binding	NULL
factor	NULL
of	NULL
50	NULL
kD	NULL
,	NULL
and	NULL
it	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
hGATA-3	NULL
on	NULL
SDS	NULL
gels	NULL
is	NULL
approximately	NULL
50	NULL
kD	NULL
(	NULL
18	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
protein	NULL
bound	NULL
by	NULL
this	NULL
presumptive	NULL
regulatory	NULL
element	NULL
may	NULL
be	NULL
due	NULL
to	NULL
overlap	NULL
of	NULL
those	NULL
sequences	NULL
with	NULL
GATA	NULL
site	NULL
2	NULL
of	NULL
the	NULL
LTR	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
;	NULL
6	NULL
)	NULL
.	NULL

If	NULL
the	NULL
binding	NULL
protein	NULL
identified	NULL
in	NULL
that	NULL
study	NULL
is	NULL
hGATA-3	NULL
,	NULL
these	NULL
results	NULL
taken	NULL
together	NULL
suggest	NULL
that	NULL
hGATA-3	NULL
might	NULL
function	NULL
as	NULL
a	NULL
negative	NULL
regulatory	NULL
factor	NULL
when	NULL
placed	NULL
in	NULL
context	NULL
with	NULL
other	NULL
regulatory	NULL
proteins	NULL
within	NULL
the	NULL
IL-2	NULL
NRE	NULL
regulatory	NULL
module	NULL
,	NULL
and	NULL
thus	NULL
hGATA-3	NULL
could	NULL
have	NULL
the	NULL
property	NULL
of	NULL
being	NULL
able	NULL
to	NULL
act	NULL
as	NULL
either	NULL
a	NULL
context-dependent	NULL
positive	NULL
(	NULL
18	NULL
,	NULL
27	NULL
)	NULL
or	NULL
negative	NULL
(	NULL
39	NULL
)	NULL
transcription	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
we	NULL
should	NULL
be	NULL
careful	NULL
to	NULL
point	NULL
out	NULL
that	NULL
mutation	NULL
of	NULL
GATA	NULL
sites	NULL
2	NULL
or	NULL
3	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
display	NULL
only	NULL
slight	NULL
alteration	NULL
in	NULL
phenotypic	NULL
effect	NULL
when	NULL
these	NULL
mutants	NULL
are	NULL
transfected	NULL
into	NULL
HeLa	NULL
or	NULL
Jurkat	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
,	NULL
mutations	NULL
which	NULL
should	NULL
have	NULL
theoretically	NULL
disrupted	NULL
cooperative	NULL
interactions	NULL
with	NULL
any	NULL
other	NULL
protein	NULL
bound	NULL
nearby	NULL
(	NULL
e.g	NULL
.	NULL

those	NULL
interacting	NULL
with	NULL
a	NULL
presumptive	NULL
IL-2	NULL
NRE-associated	NULL
protein	NULL
or	NULL
with	NULL
c-myb	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
one	NULL
of	NULL
the	NULL
two	NULL
NF-xB	NULL
binding	NULL
sites	NULL
,	NULL
one	NULL
of	NULL
the	NULL
three	NULL
Spl	NULL
binding	NULL
sites	NULL
or	NULL
the	NULL
CAP-site	NULL
proximal	NULL
LBP-1	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
or	NULL
repression	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
HIV-1	NULL
transcription	NULL
(	NULL
5	NULL
,	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

12	NULL
2835	NULL
A	NULL
hGATA-3	NULL
HeLa	NULL
cells	NULL
5	NULL
_I	NULL
j-	NULL
HIV-1	NULL
we	NULL
429-128	NULL
*	NULL
noGATA	NULL
d29-1	NULL
I	NULL
I	NULL
U	NULL
T	NULL
2	NULL
4	NULL
6	NULL
8	NULL
fold	NULL
frans-activation	NULL
B	NULL
Jurkat	NULL
cells	NULL
HIV-1	NULL
th-l	NULL
|_.|	NULL
noGATA	NULL
RA	NULL
uninduced	NULL
cells	NULL
(	NULL
C	NULL
--	NULL
I	NULL
PHA	NULL
+	NULL
PMA	NULL
I	NULL
T	NULL
T	NULL
T	NULL
I	NULL
|	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
fold	NULL
activation	NULL
C	NULL
§	NULL
4	NULL
3	NULL
2	NULL
1	NULL
HIV-1	NULL
wt	NULL
noGATA	NULL
I	NULL
I	NULL
I	NULL
1	NULL
I	NULL
I	NULL
~400	NULL
~300	NULL
+200	NULL
100	NULL
+1	NULL
+80	NULL
LTR	NULL
U3	NULL
,	NULL
distance	NULL
from	NULL
HIV	NULL
CAP	NULL
site	NULL
(	NULL
+1	NULL
)	NULL
Figure	NULL
3.	NULL
hGATA-3	NULL
regulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
in	NULL
transfected	NULL
HeLa	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
.	NULL

hGATA-3	NULL
frans-activates	NULL
HIV-1	NULL
LTR-driven	NULL
transcription	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
using	NULL
either	NULL
the	NULL
HIVWt/CAT	NULL
or	NULL
noGATA/CAT	NULL
plasmids	NULL
with	NULL
sense	NULL
(	NULL
s	NULL
)	NULL
hGATA-3	NULL
,	NULL
hGATA	NULL
429-128	NULL
,	NULL
or	NULL
antisense	NULL
(	NULL
as	NULL
)	NULL
hGATA-3	NULL
plasmids	NULL
as	NULL
indicated	NULL
to	NULL
the	NULL
left	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
the	NULL
CAT	NULL
assay	NULL
results	NULL
were	NULL
quantified	NULL
by	NULL
determining	NULL
the	NULL
amount	NULL
of	NULL
acetylated	NULL
[	NULL
'	NULL
C	NULL
]	NULL
chloramphenicol	NULL
produced	NULL
in	NULL
enzymatic	NULL
assay	NULL
;	NULL
the	NULL
degree	NULL
of	NULL
conversion	NULL
was	NULL
quantitated	NULL
on	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
conversion	NULL
by	NULL
cotransfection	NULL
with	NULL
antisense	NULL
hGATA-3	NULL
,	NULL
and	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
.	NULL

hGATA-3-binding	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
trans-activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-1/CAT	NULL
plasmids	NULL
described	NULL
below	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
extracts	NULL
(	NULL
normalized	NULL
for	NULL
equal	NULL
amounts	NULL
of	NULL
luciferase	NULL
activity	NULL
)	NULL
were	NULL
used	NULL
in	NULL
CAT	NULL
assays	NULL
as	NULL
above	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
quantified	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
,	NULL
and	NULL
the	NULL
results	NULL
shown	NULL
are	NULL
the	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
uninduced	NULL
HIVWt/CAT	NULL
transfection	NULL
conversion	NULL
percentage	NULL
normalized	NULL
as	NULL
1	NULL
.	NULL

The	NULL
open	NULL
bars	NULL
represent	NULL
the	NULL
transfection	NULL
results	NULL
of	NULL
cells	NULL
stimulated	NULL
by	NULL
PMA	NULL
+	NULL
PHA	NULL
and	NULL
the	NULL
shaded	NULL
bar	NULL
are	NULL
those	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
induction	NULL
.	NULL

(	NULL
C	NULL
)	NULL
.	NULL

HIV-1	NULL
LTR	NULL
wild	NULL
type	NULL
and	NULL
mutations	NULL
.	NULL

Line	NULL
1	NULL
:	NULL
the	NULL
DNA	NULL
sequence	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
nucleotides	NULL
-376	NULL
to	NULL
+80	NULL
.	NULL

The	NULL
noGATA	NULL
construct	NULL
(	NULL
line	NULL
2	NULL
)	NULL
represents	NULL
a	NULL
plasmid	NULL
in	NULL
which	NULL
each	NULL
of	NULL
the	NULL
GATA	NULL
binding	NULL
sites	NULL
was	NULL
mutated	NULL
by	NULL
PCR	NULL
(	NULL
black	NULL
boxes	NULL
)	NULL
into	NULL
unique	NULL
restriction	NULL
enzymes	NULL
sites	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Since	NULL
deletion	NULL
of	NULL
GATA	NULL
site	NULL
6	NULL
does	NULL
not	NULL
show	NULL
a	NULL
functional	NULL
difference	NULL
from	NULL
the	NULL
wild	NULL
type	NULL
HIV-1	NULL
LTR	NULL
in	NULL
transfection	NULL
analysis	NULL
(	NULL
4,31	NULL
)	NULL
,	NULL
the	NULL
noGATA	NULL
construct	NULL
contains	NULL
only	NULL
the	NULL
LTR	NULL
sequences	NULL
from	NULL
-376	NULL
to	NULL
+80	NULL
.	NULL

All	NULL
of	NULL
the	NULL
mutation	NULL
LTRs	NULL
were	NULL
then	NULL
subcloned	NULL
5	NULL
'	NULL
to	NULL
a	NULL
promoterless	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
(	NULL
pCATbasic	NULL
;	NULL
Promega	NULL
)	NULL
and	NULL
all	NULL
of	NULL
the	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

10	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
individual	NULL
GATA	NULL
binding	NULL
sites	NULL
resulted	NULL
in	NULL
only	NULL
very	NULL
small	NULL
quantitative	NULL
changes	NULL
in	NULL
HIV-1-LTR	NULL
mediated	NULL
transcription	NULL
;	NULL
only	NULL
by	NULL
mutation	NULL
of	NULL
all	NULL
of	NULL
the	NULL
GATA	NULL
sites	NULL
within	NULL
the	NULL
LTR	NULL
do	NULL
we	NULL
see	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR-mediated	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
that	NULL
cumulative	NULL
effect	NULL
is	NULL
smaller	NULL
(	NULL
by	NULL
2-	NULL
to	NULL
3-fold	NULL
)	NULL
than	NULL
the	NULL
quite	NULL
dramatic	NULL
effect	NULL
,	NULL
for	NULL
example	NULL
,	NULL
of	NULL
mutation	NULL
of	NULL
the	NULL
two	NULL
NF-xB	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
the	NULL
data	NULL
clearly	NULL
demonstrate	NULL
that	NULL
the	NULL
GATA	NULL
binding	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
maximal	NULL
expression	NULL
of	NULL
HIV-1	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
mutations	NULL
decrease	NULL
activity	NULL
in	NULL
both	NULL
stimulated	NULL
and	NULL
unstimulated	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
do	NULL
not	NULL
affect	NULL
the	NULL
relative	NULL
inducibility	NULL
of	NULL
viral	NULL
transcription	NULL
through	NULL
the	NULL
PHA	NULL
+	NULL
PMA	NULL
stimulatory	NULL
pathway	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
interaction	NULL
2836	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

12	NULL
of	NULL
hGATA-3	NULL
with	NULL
the	NULL
basal	NULL
transcriptional	NULL
apparatus	NULL
is	NULL
cumulative	NULL
and	NULL
independent	NULL
of	NULL
phorbol	NULL
ester	NULL
or	NULL
general	NULL
mitogenic	NULL
stimulation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
by	NULL
the	NULL
HIV	NULL
envelope	NULL
glycoprotein	NULL
gp120	NULL
may	NULL
be	NULL
an	NULL
early	NULL
step	NULL
in	NULL
determining	NULL
the	NULL
cell	NULL
type	NULL
selectivity	NULL
of	NULL
the	NULL
virus	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

After	NULL
HIV	NULL
enters	NULL
a	NULL
cell	NULL
,	NULL
a	NULL
continuation	NULL
in	NULL
this	NULL
selectivity	NULL
of	NULL
tissue-specific	NULL
expression	NULL
might	NULL
logically	NULL
be	NULL
assumed	NULL
to	NULL
be	NULL
governed	NULL
by	NULL
further	NULL
cell	NULL
type-restricted	NULL
mechanisms	NULL
,	NULL
including	NULL
the	NULL
involvement	NULL
of	NULL
tissue-restricted	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

The	NULL
findings	NULL
presented	NULL
here	NULL
that	NULL
hGATA-3	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
in	NULL
T	NULL
cells	NULL
provides	NULL
direct	NULL
evidence	NULL
for	NULL
a	NULL
T	NULL
lymphocyte-restricted	NULL
transcription	NULL
factor	NULL
which	NULL
modulates	NULL
transcription	NULL
of	NULL
the	NULL
virus	NULL
in	NULL
which	NULL
the	NULL
tropism	NULL
of	NULL
infection	NULL
is	NULL
partially	NULL
consistent	NULL
with	NULL
the	NULL
documented	NULL
expression	NULL
of	NULL
a	NULL
tissue-restricted	NULL
transcription	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
HIV	NULL
replicates	NULL
well	NULL
in	NULL
cell	NULL
types	NULL
which	NULL
do	NULL
not	NULL
express	NULL
GATA-3	NULL
.	NULL

Among	NULL
the	NULL
known	NULL
members	NULL
of	NULL
this	NULL
family	NULL
,	NULL
GATA-2	NULL
is	NULL
expressed	NULL
far	NULL
more	NULL
broadly	NULL
than	NULL
the	NULL
other	NULL
family	NULL
members	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
GATA-2	NULL
and	NULL
GATA-3	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
subset	NULL
of	NULL
consensus	NULL
DNA	NULL
sequences	NULL
in	NULL
vitro	NULL
(	NULL
46	NULL
)	NULL
.	NULL

HIV-1	NULL
might	NULL
also	NULL
be	NULL
regulated	NULL
by	NULL
other	NULL
GATA	NULL
factors	NULL
in	NULL
specific	NULL
myeloid	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
or	NULL
neuronal	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
cell	NULL
lineages	NULL
,	NULL
other	NULL
cell	NULL
types	NULL
in	NULL
which	NULL
HIV-1	NULL
is	NULL
known	NULL
to	NULL
exert	NULL
cytopathic	NULL
effects	NULL
(	NULL
1	NULL
)	NULL
and	NULL
which	NULL
also	NULL
express	NULL
other	NULL
GATA	NULL
factors	NULL
(	NULL
17	NULL
)	NULL
,	NULL
is	NULL
thus	NULL
a	NULL
subject	NULL
of	NULL
considerable	NULL
interest	NULL
,	NULL
but	NULL
awaits	NULL
further	NULL
detailed	NULL
analysis	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
L.J.Ko	NULL
,	NULL
M.W.Leonard	NULL
and	NULL
W.Niu	NULL
for	NULL
constructive	NULL
criticism	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
for	NULL
assistance	NULL
with	NULL
some	NULL
of	NULL
these	NULL
experiments	NULL
,	NULL
and	NULL
S.Goff	NULL
(	NULL
Columbia	NULL
Univ	NULL
.	NULL
)	NULL

for	NULL
the	NULL
HIV-1	NULL
wt	NULL
LTR	NULL
in	NULL
plasmid	NULL
pHXB2	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grant	NULL
GM	NULL
28896	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Vaishnav	NULL
,	NULL
Y.	NULL
N.	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Ann	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
60	NULL
,	NULL
577-630	NULL
.	NULL

2	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
58	NULL
,	NULL
423-426	NULL
.	NULL

3	NULL
.	NULL

McCune	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
,	NULL
64	NULL
,	NULL
351-363	NULL
.	NULL

4	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
,	NULL
41	NULL
.	NULL

5	NULL
.	NULL

Kato	NULL
,	NULL
H.	NULL
,	NULL
Horikoshi	NULL
,	NULL
M.	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
,	NULL
251	NULL
,	NULL
1476-1479	NULL
.	NULL

6	NULL
.	NULL

Hauber	NULL
,	NULL
J.	NULL
and	NULL
Cullen	NULL
,	NULL
B.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virology	NULL
,	NULL
62	NULL
,	NULL
673-679	NULL
.	NULL

7	NULL
.	NULL

Jakobovits	NULL
,	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Jakobovits	NULL
,	NULL
E.	NULL
B.	NULL
and	NULL
Capon	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
2555-2561	NULL
.	NULL

8	NULL
.	NULL

Muesing	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
H.	NULL
and	NULL
Capon	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
48	NULL
,	NULL
691-701	NULL
.	NULL

9	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
and	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Virology	NULL
,	NULL
66	NULL
,	NULL
39-149	NULL
.	NULL

10	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A.	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
,	NULL
232	NULL
,	NULL
755-759	NULL
.	NULL

11	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
Garcia	NULL
,	NULL
J.	NULL
,	NULL
Wu	NULL
,	NULL
F.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R.	NULL
,	NULL
Gonzalez	NULL
,	NULL
J.	NULL
and	NULL
Gaynor	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Virology	NULL
,	NULL
63	NULL
,	NULL
2585-2591	NULL
.	NULL

12	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

13	NULL
.	NULL

Franza	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Jr.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
II	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Sciene	NULL
,	NULL
239	NULL
,	NULL
1150-1153	NULL
.	NULL

14	NULL
.	NULL

Dasgupta	NULL
,	NULL
P.	NULL
,	NULL
Saikumar	NULL
,	NULL
P.	NULL
,	NULL
Reddy	NULL
,	NULL
C.	NULL
D.	NULL
and	NULL
Reddy	NULL
,	NULL
E.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
,	NULL
87	NULL
,	NULL
8090-8094	NULL
.	NULL

15	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
Utz	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Toole	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Emmel	NULL
,	NULL
E.	NULL
A.	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
,	NULL
241	NULL
,	NULL
202-205	NULL
.	NULL

16	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
8526-8530	NULL
.	NULL

17	NULL
.	NULL

Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
1650-1662	NULL
.	NULL

18	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
George	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ting	NULL
,	NULL
P.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
2778-2784	NULL
.	NULL

19	NULL
.	NULL

Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Lim	NULL
,	NULL
K.-C.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
unpublished	NULL
)	NULL
.	NULL

20	NULL
.	NULL

Kommhauser	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
LaVail	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Mayo	NULL
,	NULL
K.	NULL
E.	NULL
and	NULL
J.	NULL
D.	NULL
Engel	NULL
(	NULL
unpublished	NULL
)	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26.	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Pfohl	NULL
,	NULL
J.	NULL
L.	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Molec	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
28	NULL
.	NULL

29	NULL
.	NULL

Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Burgess	NULL
,	NULL
S.	NULL
,	NULL
Bolce	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Harland	NULL
,	NULL
R.	NULL
M.	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
,	NULL
88	NULL
,	NULL
10642-10646	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
Yang	NULL
,	NULL
L.-H.	NULL
,	NULL
Morle	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
,	NULL
86	NULL
,	NULL
6714-6718	NULL
.	NULL

Marine	NULL
,	NULL
J.	NULL
and	NULL
Winoto	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A.	NULL
,	NULL
88	NULL
,	NULL
7284-7288	NULL
.	NULL

Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Hata	NULL
,	NULL
S.	NULL
,	NULL
Brocklehurst	NULL
,	NULL
C.	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
,	NULL
247	NULL
,	NULL
1225-1229.	NULL
.	NULL

Takeda	NULL
,	NULL
J.	NULL
,	NULL
Cheng	NULL
,	NULL
A.	NULL
,	NULL
Mauxion	NULL
,	NULL
F.	NULL
,	NULL
Nelson	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Newberry	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
and	NULL
Loh	NULL
,	NULL
D.	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
,	NULL
5027-5035	NULL
.	NULL

Winoto	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
729-733	NULL
.	NULL

11	NULL
,	NULL
5671-5680	NULL
.	NULL

Evans	NULL
,	NULL
T.	NULL
,	NULL
Reitman	NULL
,	NULL
M.	NULL
and	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
USA	NULL
,	NULL
85	NULL
,	NULL
5976-5980	NULL
.	NULL

Tsai	NULL
,	NULL
S.-F.	NULL
,	NULL
Martin	NULL
,	NULL
D.	NULL
I.	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
D'Andrea	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Wong	NULL
,	NULL
G.	NULL
G.	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
339	NULL
,	NULL
446-451.	NULL
.	NULL

Gallarda	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Foley	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
Yang	NULL
,	NULL
Z.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
1845-1859.	NULL
.	NULL

Yang	NULL
,	NULL
Z.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
unpublished	NULL
)	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
and	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1973	NULL
)	NULL
Virol	NULL
.	NULL

,	NULL
52	NULL
,	NULL
456-467.	NULL
.	NULL

Rosenthal	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Meth	NULL
.	NULL

Enzymol	NULL
.	NULL

,	NULL
152	NULL
,	NULL
704.	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
F.	NULL
and	NULL
Howard	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
2	NULL
,	NULL
1044-1051.	NULL
.	NULL

Choi	NULL
,	NULL
O.-R.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
,	NULL
323	NULL
,	NULL
731-734.	NULL
.	NULL

Yang	NULL
,	NULL
Z.	NULL
,	NULL
Gu	NULL
,	NULL
L.	NULL
,	NULL
Bories	NULL
,	NULL
D.	NULL
,	NULL
Romeo	NULL
,	NULL
P.-H.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
unpublished	NULL
)	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
Wiskocil	NULL
,	NULL
R.	NULL
L.	NULL
and	NULL
Stobo	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
133	NULL
,	NULL
123-128.	NULL
.	NULL

Joulin	NULL
,	NULL
V.	NULL
,	NULL
Bories	NULL
,	NULL
D.	NULL
,	NULL
Eleouct	NULL
,	NULL
J.-F.	NULL
,	NULL
Labastie	NULL
,	NULL
M.-C.	NULL
,	NULL
Chretien	NULL
,	NULL
S.	NULL
,	NULL
Mattei	NULL
,	NULL
M.-G.	NULL
and	NULL
Romeo	NULL
,	NULL
P.-H.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
1809-1816.	NULL
.	NULL

Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
George	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Kornhauser	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Ting	NULL
,	NULL
P.	NULL
and	NULL
Yamamoto	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Sem	NULL
.	NULL

Hemat	NULL
.	NULL

,	NULL
28	NULL
,	NULL
158-169.	NULL
.	NULL

Sattentau	NULL
,	NULL
Q.	NULL
J.	NULL
and	NULL
Weiss	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
52	NULL
,	NULL
631-633.	NULL
.	NULL

Shioda	NULL
,	NULL
T.	NULL
,	NULL
Levy	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
and	NULL
Mayer	NULL
,	NULL
C.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
,	NULL
349	NULL
,	NULL
167-169.	NULL
.	NULL

Martin	NULL
,	NULL
D.	NULL
I.	NULL
K.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
I.	NULL
,	NULL
Mutter	NULL
,	NULL
G.	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
344	NULL
,	NULL
444-447.	NULL
.	NULL

Romeo	NULL
,	NULL
P.-H.	NULL
,	NULL
Prandini	NULL
,	NULL
M.-H.	NULL
,	NULL
Joulin	NULL
,	NULL
V.	NULL
,	NULL
Mignotte	NULL
,	NULL
V.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Marguerie	NULL
,	NULL
G.	NULL
and	NULL
Uzan	NULL
,	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
344	NULL
,	NULL
447-449.	NULL
.	NULL

Starcich	NULL
,	NULL
B.	NULL
,	NULL
Ratner	NULL
,	NULL
L.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Okamoto	NULL
,	NULL
T.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
and	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
,	NULL
227	NULL
,	NULL
538-540.	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Hannibal	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Cossman	NULL
,	NULL
R.	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

66	NULL
,	NULL
3961-3965.	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

